US OptionsDetailed Quotes
RVPH250117P5500
- 2.50
- 0.000.00%
15min DelayClose Jan 17 16:00 ET
0.00High0.00Low
2.50Open2.50Pre Close0 Volume0 Open Interest5.50Strike Price0.00Turnover0.00%IV-69.49%PremiumJan 17, 2025Expiry Date3.73Intrinsic Value100Multiplier-3DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type--Delta--Gamma0.48Leverage Ratio--Theta--Rho--Eff Leverage--Vega
Reviva Pharmaceuticals Stock Discussion
Sign in to post a comment
$Reviva Pharmaceuticals (RVPH.US)$ Institutions steal the whole float yet?
1
$Reviva Pharmaceuticals (RVPH.US)$ LET IT FLYYY
1
$Reviva Pharmaceuticals (RVPH.US)$ Reviva Announces Proposed Public Offering
GlobeNewswire· 6 mins ago
GlobeNewswire· 6 mins ago
3
4
$Reviva Pharmaceuticals (RVPH.US)$
Reviva Announces Positive Preliminary Topline Data for the Long-Term Open Label Extension Portion of the Phase 3 RECOVER Study Evaluating Brilaroxazine in Schizophrenia
Monday, 16th December at 8:00 am
– Once daily brilaroxazine demonstrated favorable long-term safety and robust broad-spectrum efficacy sustained over 1-year –
– Generally well-tolerated with low rates of adverse events and discontinuation –
– Full data set from open-label extension (OLE) of R...
Reviva Announces Positive Preliminary Topline Data for the Long-Term Open Label Extension Portion of the Phase 3 RECOVER Study Evaluating Brilaroxazine in Schizophrenia
Monday, 16th December at 8:00 am
– Once daily brilaroxazine demonstrated favorable long-term safety and robust broad-spectrum efficacy sustained over 1-year –
– Generally well-tolerated with low rates of adverse events and discontinuation –
– Full data set from open-label extension (OLE) of R...
1
$ABVC BioPharma (ABVC.US)$ - Progress continues in our ADHD program with Phase IIb trials at multiple prominent sites. We aim to have an interim report by Q4 2024. ABV-1601 for MDD in cancer patients has completed Phase I study preparation, including the Site Initiation Visit (SIV). The study is set to initiate by the end of 2024.
$Ascent Solar Technologies (ASTI.US)$- Following delivery and the successful completion of the on-orbi...
$Ascent Solar Technologies (ASTI.US)$- Following delivery and the successful completion of the on-orbi...
28
9
7
$Reviva Pharmaceuticals (RVPH.US)$Analysts Think This $3 Stock Has 430% Upside Potential - Trades Of The Day
$Reviva Pharmaceuticals (RVPH.US)$Reviva: Upcoming Events Generate Excitement, But Cash Is Low (RVPH)" data-render="ssr
$bluebird bio (BLUE.US)$ $Direxion Daily FTSE China Bear 3X Shares ETF (YANG.US)$ $New Era Helium (NEHC.US)$ $Jet.AI (JTAI.US)$ $Volato Group (SOAR.US)$ $Reviva Pharmaceuticals (RVPH.US)$ $Nanobiotix (NBTX.US)$ $Gelteq (GELS.US)$ $The Glimpse (VRAR.US)$ $Processa Pharmaceuticals (PCSA.US)$ $TNL Mediagene (TNMG.US)$ $Cumberland Pharmaceuticals (CPIX.US)$ $Chimerix (CMRX.US)$
📊⚡️📊
📊⚡️📊
4
1
$Fangdd Network (DUO.US)$ $TheRealReal (REAL.US)$ $Asset Entities (ASST.US)$ $Quantum-Si (QSI.US)$ $Reviva Pharmaceuticals (RVPH.US)$ $MDJM Ltd (UOKA.US)$ $Sonnet BioTherapeutic (SONN.US)$ $Procaps (PROC.US)$ $Gelteq (GELS.US)$ $Gaxos.ai (GXAI.US)$ $Zeo Energy (ZEO.US)$ $Metagenomi Technologies, LLC (MGX.US)$ $Huize (HUIZ.US)$ $LeddarTech (LDTC.US)$
📊⚡️📊
📊⚡️📊
8
3
$Reviva Pharmaceuticals (RVPH.US)$ why it’s on circuit breaker? any news?
2
No comment yet
73277606 : soon I think